Quarterly report · Q1
2370.TEDINET S100Q5ZZ
Period2022-10-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 32
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥185m | 2022-10-01 → 2022-12-31 | Standalone | Net sales |
| Revenue | ¥634m | 2021-10-01 → 2022-09-30 | Standalone | Net sales (5-year summary) |
| Revenue | ¥173m | 2021-10-01 → 2021-12-31 | Standalone | Net sales |
| Operating income | −¥325m | 2022-10-01 → 2022-12-31 | Standalone | Operating income |
| Operating income | −¥340m | 2021-10-01 → 2021-12-31 | Standalone | Operating income |
| Ordinary income | −¥324m | 2022-10-01 → 2022-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥1.3bn | 2021-10-01 → 2022-09-30 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥341m | 2021-10-01 → 2021-12-31 | Standalone | Ordinary income |
| Profit before tax | −¥324m | 2022-10-01 → 2022-12-31 | Standalone | Income before income taxes |
| Profit before tax | −¥341m | 2021-10-01 → 2021-12-31 | Standalone | Income before income taxes |
| Net income | −¥326m | 2022-10-01 → 2022-12-31 | Standalone | Profit loss |
| Net income | −¥1.3bn | 2021-10-01 → 2022-09-30 | Standalone | Net income loss (5-year summary) |
| Net income | −¥342m | 2021-10-01 → 2021-12-31 | Standalone | Profit loss |
| Total assets | ¥5.5bn | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥6.1bn | at 2022-09-30 | Standalone | Assets |
| Total assets | ¥5.5bn | at 2021-12-31 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥448m | at 2022-12-31 | Standalone | Liabilities |
| Total liabilities | ¥566m | at 2022-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥5.0bn | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥5.5bn | at 2022-09-30 | Standalone | Net assets |
| Net assets / equity | ¥5.0bn | at 2021-12-31 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥4.1bn | at 2022-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥4.5bn | at 2022-09-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥-1.54 | 2022-10-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-6.33 | 2021-10-01 → 2022-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.88 | 2021-10-01 → 2021-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 91.8% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.7% | at 2022-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.6% | at 2021-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 211,730,423 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 211,730,423 | at 2022-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 184,950,423 | at 2021-12-31 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2022-12-31 | −¥161m |
| jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥158,000 |
| jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥158,000 |
| jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segment | segment profit | 2022-10-01 → 2022-12-31 | −¥107m |
| jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥185m |
| jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥185m |
| jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segment | segment profit | 2022-10-01 → 2022-12-31 | −¥57m |
| —segment total | revenue | 2022-10-01 → 2022-12-31 | ¥185m |
| —segment total | revenue external | 2022-10-01 → 2022-12-31 | ¥185m |
| —segment total | segment profit | 2022-10-01 → 2022-12-31 | −¥164m |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2021-12-31 | −¥135m |
| jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue | 2021-10-01 → 2021-12-31 | ¥47,000 |
| jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue external | 2021-10-01 → 2021-12-31 | ¥47,000 |
| jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segment | segment profit | 2021-10-01 → 2021-12-31 | −¥157m |
| jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue | 2021-10-01 → 2021-12-31 | ¥173m |
| jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue external | 2021-10-01 → 2021-12-31 | ¥173m |
| jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segment | segment profit | 2021-10-01 → 2021-12-31 | −¥47m |
| —segment total | revenue | 2021-10-01 → 2021-12-31 | ¥173m |
| —segment total | revenue external | 2021-10-01 → 2021-12-31 | ¥173m |
| —segment total | segment profit | 2021-10-01 → 2021-12-31 | −¥205m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 299
| Item | Context | Value | Unit |
|---|---|---|---|
| Other noi | CurrentYTDDuration_NonConsolidatedMember | 230000 | JPY |
| Non operating income | Prior1YTDDuration_NonConsolidatedMember | 5665000 | JPY |
| Non operating income | CurrentYTDDuration_NonConsolidatedMember | 5775000 | JPY |
| Interest expenses noe | Prior1YTDDuration_NonConsolidatedMember | 34000 | JPY |
| Interest expenses noe | CurrentYTDDuration_NonConsolidatedMember | 17000 | JPY |
| Foreign exchange losses noe | Prior1YTDDuration_NonConsolidatedMember | 75000 | JPY |
| Foreign exchange losses noe | CurrentYTDDuration_NonConsolidatedMember | 95000 | JPY |
| Loss on investments in partnership noe | Prior1YTDDuration_NonConsolidatedMember | 5490000 | JPY |
| Loss on investments in partnership noe | CurrentYTDDuration_NonConsolidatedMember | 4645000 | JPY |
| Stock issuance cost noe | Prior1YTDDuration_NonConsolidatedMember | 1125000 | JPY |
| Stock issuance cost noe | CurrentYTDDuration_NonConsolidatedMember | － | JPY |
| Non operating expenses | Prior1YTDDuration_NonConsolidatedMember | 6726000 | JPY |
| Non operating expenses | CurrentYTDDuration_NonConsolidatedMember | 4758000 | JPY |
| Ordinary income | Prior1YTDDuration_NonConsolidatedMember | -340792000 | JPY |
| Ordinary income | CurrentYTDDuration_NonConsolidatedMember | -324481000 | JPY |
| Income before income taxes | Prior1YTDDuration_NonConsolidatedMember | -340792000 | JPY |
| Income before income taxes | CurrentYTDDuration_NonConsolidatedMember | -324481000 | JPY |
| Income taxes current | Prior1YTDDuration_NonConsolidatedMember | 1364000 | JPY |
| Income taxes current | CurrentYTDDuration_NonConsolidatedMember | 1052000 | JPY |
| Income taxes deferred | Prior1YTDDuration_NonConsolidatedMember | -13000 | JPY |
| Income taxes deferred | CurrentYTDDuration_NonConsolidatedMember | -13000 | JPY |
| Income taxes | Prior1YTDDuration_NonConsolidatedMember | 1351000 | JPY |
| Income taxes | CurrentYTDDuration_NonConsolidatedMember | 1039000 | JPY |
| Profit loss | Prior1YTDDuration_NonConsolidatedMember | -342144000 | JPY |
| Profit loss | CurrentYTDDuration_NonConsolidatedMember | -325521000 | JPY |
| Revenues from external customers | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E05351-000ContractCellManufacturingBusinessReportableSegmentsMember | 172807000 | JPY |
| Revenues from external customers | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E05351-000CellularAndTissueBasedProductBusinessReportableSegmentsMember | 47000 | JPY |
| Revenues from external customers | Prior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember | 172854000 | JPY |
| Revenues from external customers | Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration_NonConsolidatedMember | 172854000 | JPY |
| Transactions with other segments | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E05351-000ContractCellManufacturingBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E05351-000CellularAndTissueBasedProductBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_NonConsolidatedMember | － | JPY |
| Net sales | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E05351-000ContractCellManufacturingBusinessReportableSegmentsMember | 172807000 | JPY |
| Net sales | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E05351-000CellularAndTissueBasedProductBusinessReportableSegmentsMember | 47000 | JPY |
| Net sales | Prior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember | 172854000 | JPY |
| Net sales | Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1YTDDuration_NonConsolidatedMember | 172854000 | JPY |
| Operating income | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E05351-000ContractCellManufacturingBusinessReportableSegmentsMember | -47193000 | JPY |
| Operating income | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E05351-000CellularAndTissueBasedProductBusinessReportableSegmentsMember | -157460000 | JPY |
| Operating income | Prior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember | -204653000 | JPY |
| Operating income | Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember | -135078000 | JPY |
| Operating income | Prior1YTDDuration_NonConsolidatedMember | -339731000 | JPY |
| Revenues from external customers | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E05351-000ContractCellManufacturingBusinessReportableSegmentsMember | 184994000 | JPY |
| Revenues from external customers | CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E05351-000CellularAndTissueBasedProductBusinessReportableSegmentsMember | 158000 | JPY |
| Revenues from external customers | CurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember | 185153000 | JPY |
| Revenues from external customers | CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration_NonConsolidatedMember | 185153000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |